ChemicalBook > CAS DataBase List > NVP-BAW2881

NVP-BAW2881

Product Name
NVP-BAW2881
CAS No.
861875-60-7
Chemical Name
NVP-BAW2881
Synonyms
CS-2238;BAW2881;NVP-BAW2881;BAW2881 (NVP-BAW2881);NVP-BAW2881;NVP-BAW-2881;;NVP-BAW 2881;6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide;1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-;6-(2-amino-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethyl phenyl)amide;NVPBAW2881,inhibit,BAW 2881,NVP BAW2881,Vascular endothelial growth factor receptor,VEGFR,Inhibitor,NVP-BAW2881,BAW-2881,NVP-BAW-2881
CBNumber
CB93133229
Molecular Formula
C22H15F3N4O2
Formula Weight
424.38
MOL File
861875-60-7.mol
More
Less

NVP-BAW2881 Property

storage temp. 
Store at -20°C
solubility 
≥42.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
form 
solid
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
18910
Product name
BAW 2881
Purity
≥98%
Packaging
1mg
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
18910
Product name
BAW 2881
Purity
≥98%
Packaging
5mg
Price
$202
Updated
2024/03/01
Cayman Chemical
Product number
18910
Product name
BAW 2881
Purity
≥98%
Packaging
10mg
Price
$384
Updated
2024/03/01
Cayman Chemical
Product number
18910
Product name
BAW 2881
Purity
≥98%
Packaging
25mg
Price
$848
Updated
2024/03/01
TRC
Product number
A630190
Product name
6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide
Packaging
1mg
Price
$60
Updated
2021/12/16
More
Less

NVP-BAW2881 Chemical Properties,Usage,Production

Description

BAW 2881 is a vascular endothelial growth factor receptor (VEGFR) inhibitor (IC50s = 0.82, 0.037, and 0.42 μM for hVEGFR1, 2, and 3, respectively). It inhibits Tie2 and RET with IC50 values of 0.65 and 0.41 μM, respectively, but demonstrates IC50 values great than 10 μM toward a large panel of additional kinases. BAW 2881 was shown to block VEGF-A-induced proliferation, migration, and tube formation of human umbilical vein endothelial cells and lymphatic endothelial cells in vitro. In a mouse model of psoriasis, both oral and topical administration of BAW 2881 reduced psoriasis-like inflammation in ear skin. Topical application of BAW 2881 also reduced VEGF-A-induced vascular permeability and inhibited contact hypersensitivity reactions and UV-B-induced erythema in the skin of domestic pigs.

Uses

6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide is a selective vascular endothelial growth factor (VEGF) receptor inhibitor. VEGF receptors play important roles in angiogenesis and vascular permeability.

in vitro

previous study showed that baw2881 could inhibit a limited number of kinases including c-raf, b-raf, ret, abl, and tie-2 at submicromole ic50s. baw2881 could also inhibit the ligand induced autophosphorylation of ret, pdgfr, and kit kinases. moreover, low ic50 value (0.12 ± 0.06 nm) demonstrated that baw2881 remarkably abrogated vegf induced proliferation [1].

in vivo

in a psoriasis mouse model, baw2881 was able to reduce the number of blood and lymphatic vessels and infiltrating leukocytes in the skin, and normalize the epidermal architecture. baw2881 also showed strong anti-inflammatory effects in acute inflammation models. moreover, the pretreatment with topical baw2881 could significantly inhibit vegf-a-induced vascular permeability in the skin of both pigs and mice. in addition, it was found that the topical application of baw2881 was able to reduce the inflammatory response in pig skin caused by uv-b irradiation or by contact hypersensitivity reactions [2].

IC 50

1.0-4.3 nm for vegfr1-3

References

[1] bold g et al. a novel potent oral series of vegfr2 inhibitors abrogate tumor growth by inhibiting angiogenesis. j med chem. 2016 jan 14;59(1):132-46.
[2] halin c,fahrngruber h,meingassner jg,bold g,littlewood-evans a,stuetz a,detmar m. inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. am j pathol.2008 jul;173(1):265-77.

NVP-BAW2881 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NVP-BAW2881 Suppliers

Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6393
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
Aladdin Scientific
Tel
+1-833-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57511
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354
Email
support@targetmol.com
Country
United States
ProdList
19973
Advantage
58
More
Less

View Lastest Price from NVP-BAW2881 manufacturers

Career Henan Chemical Co
Product
NVP-BAW2881 861875-60-7
Price
US $1.00/g
Min. Order
1g
Purity
99.99%
Supply Ability
200kg
Release date
2019-12-20

861875-60-7, NVP-BAW2881Related Search:


  • NVP-BAW2881
  • BAW2881
  • BAW2881 (NVP-BAW2881)
  • 6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide
  • 6-(2-amino-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethyl phenyl)amide
  • CS-2238
  • NVP-BAW2881;NVP-BAW-2881;;NVP-BAW 2881
  • 1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-
  • NVPBAW2881,inhibit,BAW 2881,NVP BAW2881,Vascular endothelial growth factor receptor,VEGFR,Inhibitor,NVP-BAW2881,BAW-2881,NVP-BAW-2881
  • 861875-60-7